Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06067139 · ClinicalTrials.gov registry record · NA

Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

A NA study of Diabetes Mellitus, Type 2 and Prediabetic State, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06067139 is a NA study of Diabetes Mellitus, Type 2 and Prediabetic State that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 300 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06067139, a NA study of Diabetes Mellitus, Type 2 and Prediabetic State, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program.

Interventions

  • OTHER Patient Education
  • OTHER SHUTi

Study Locations (1)

Oregon

  • Kaiser Permanente Center for Health Research - Portland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-08-01
Est. Completion 2027-12
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT06067139

The ClinicalTrials.gov registry entry for NCT06067139 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Patient Education is the first listed.

NCT06067139 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06067139 about?

NCT06067139 is a clinical study titled "Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk". This study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program.

What is the current status of trial NCT06067139?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-08-01. Estimated completion is 2027-12.

What conditions does trial NCT06067139 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Prediabetic State, Sleep Initiation and Maintenance Disorders.

What interventions are being tested in trial NCT06067139?

The interventions under investigation include: Patient Education (OTHER), SHUTi (OTHER).

Who is sponsoring clinical trial NCT06067139?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06067139 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.